SEARCH RESULT

Total Matching Records found : 1257

Capital shuts door on Burmese refugees-Anahita Mukherji

Over 2000 impoverished Burmese asylum-seekers from across India, camping on the streets of Delhi pleading for refugee status were dealt a double whammy. On Tuesday afternoon, even as a delegation of Burmese met UN officials to sort out their problems, they were forced out of their temporary shelter in Vasant Kunj by police, dumped into buses and rickshaws and told to find their way home. To make matters worse, their...

More »

1,333 doctors migrated abroad last year-Kounteya Sinha

While India faces an acute shortage of trained medical manpower, as many as 1,333 doctors migrated to foreign shores over the last one year. During the same period, the previous year - from April 1, 2010 to March 31, 2011 - 1,157 doctors had migrated in search of employment, and between 2009 and 2010, 1,458 doctors went abroad. This latest revelation by Union health minister Ghulam Nabi Azad on Friday comes just...

More »

A healthier India: Need to resolve conflict between drug price controls, innovation and affordable Healthcare-David Taylor

The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...

More »

Bayer to challenge Cipla’s decision to cut price of cancer drug

-PTI German pharma major Bayer has charged that Indian generic drugmaker Cipla had breached its patent rights by slashing the price of a generic version of its patent-protected cancer drug Nexavar last week. Bayer Pharma has not given its consent to Cipla to launch its generic Sorafenib (sold under the brand name Nexavar) and the company’s decision to cut the price of the life-extending kidney and liver cancer drug “is a clear...

More »

States neglecting silicosis: NHRC -Sonal Matharu

Human rights commission calls for collective efforts to provide Healthcare, compensation to victims and kin The National Human Rights Commission has slammed the Centre and state governments for neglecting workers who are suffering from silicosis—an incurable lung disease caused due to inhalation of silica in dust. The reprimand is in the form of a note that followed the commission's fourth review meeting in New Delhi that concluded on May 4. Over...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close